Ketamine and Psychedelic Therapy in Chicago, IL

How to Find Ketamine Care and a Psychedelic Therapist in Chicago

Finding ketamine treatment near you in Chicago comes down to two paths. You can go to a Chicago-area clinic for an in-person IV or intramuscular infusion, or you can do ketamine therapy at home through telehealth. Mindbloom takes the at-home path. Eligibility begins with an online clinical evaluation by an Illinois-licensed clinician, and when it is a good fit, a prescription for sublingual ketamine is filled by a licensed pharmacy and shipped to you, with clinician support before and after each session. A ketamine prescription online through a real evaluation, not a checkbox questionnaire, is what makes this both accessible and safe.

If you are looking for a psychedelic therapist, or for psychedelics near you in Chicago, it helps to know what is actually available in Illinois. Psilocybin and MDMA are not legal for therapy here, so in practice the psychedelic-class therapy you can start now is ketamine. Mindbloom pairs the medicine with the guided preparation and integration people associate with psychedelic therapy, which you can read more about in this psychedelic therapy guide.

Chicago is large and polycentric, and in-person options are spread across it. Ketamine and Spravato providers cluster downtown around the Loop and Millennium Park, along the North Side in neighborhoods like Lincoln Park and Lakeview, and out in suburbs such as River Forest and Oak Lawn, so in-person access and travel times vary a lot depending on where you live. At-home care removes the drive entirely, which is part of why it fits a metro this size. Ketamine therapy is legal statewide, and you can learn more on our ketamine therapy in Illinois page.

Your Ketamine and Psychedelic Therapy Options in Chicago

Chicago residents weigh a few options for ketamine and psychedelic therapy. Here is how they compare on setting, format, and cost as of 2026.

Psilocybin, MDMA, LSD, and ayahuasca all draw interest, but none is legally available for therapy in Illinois today, and no Chicago ordinance changes that.¹⁰ ¹² That is why ketamine is the psychedelic-class therapy Chicago residents can actually begin now. On the evidence it holds up: Mindbloom's reported depression response of 56.6% is at or above the roughly 37% to 42% reported in the largest controlled trials of single-dose psilocybin for depression, on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

For in-clinic ketamine, Chicago clinics post a range of prices. Balance Ketamine lists $400 to $475 for an initial infusion and $300 to $375 for subsequent infusions, with self-pay generally in the $400 to $600 range,¹³ ¹⁴ and Able Psychiatry in Lincoln Park lists ketamine treatment at $350 per session.¹⁵ Other IV and IM providers operate across the North Side and the suburbs. Spravato, the in-clinic esketamine nasal spray, is offered at several Chicago-area psychiatric practices, including downtown near Millennium Park, and may be covered by insurance for people who qualify, subject to the insurer's approval. Mindbloom does not run a clinic in Chicago; it is telehealth, so the comparison here is at-home care versus going to one of these in-person providers, and you can read how at-home sublingual ketamine compares with IV.

What Ketamine Therapy Can Help With

Depression is the condition ketamine therapy is used for most, and it is Mindbloom's flagship indication. In its peer-reviewed subcutaneous study, Mindbloom reported a 56.6% depression response rate and 27.7% remission.¹ Ketamine treatment for depression is the core of what Mindbloom does, and depression care is available to eligible adults across Chicago by telehealth.

Beyond depression, Mindbloom is the only at-home ketamine provider with peer-reviewed PTSD outcomes, reporting a 76.7% response rate.¹ Its programs also address anxiety, grief, burnout, and sleep. Mindbloom does not claim conditions its evidence does not support, so you will not find promises here for chronic pain, OCD, or addiction.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. The outcomes below draw on Mindbloom's peer-reviewed subcutaneous study (Parks 2026), which measured depression, anxiety, and PTSD in a single study.¹ Mindbloom also has two earlier peer-reviewed studies of its sublingual protocol (Hull 2022 and Mathai 2024), plus research preprints extending the evidence to grief, burnout, and sleep, the largest published evidence base in at-home ketamine therapy. It is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes.

_{¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least a 50% reduction (PHQ-9 or GAD-7) or at least a 10-point reduction (PCL-5); remission = a final PHQ-9 or GAD-7 under 5, or at least a 10-point reduction with PCL-5 under 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored programs that use the psychedelic modality to work toward specific outcomes, not just a prescription. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How Mindbloom's reported outcomes compare with published studies of other treatments:

• Mindbloom's reported depression response is comparable to the rate reported in a study of first-line SSRIs, without a daily medication and faster, at 2 sessions versus four to six weeks.¹ ⁵
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial, at 76.7% versus 67%.¹ ⁶
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time, at 76% response, within its 66% to 82% range, reached in about 6 sessions versus 16.² ⁷

For how at-home sublingual compares with in-clinic IV specifically, see Mindbloom's comparison of sublingual and IV ketamine.

Is Ketamine Therapy Legal in Illinois?

Yes. Ketamine is legal to prescribe in Illinois and in every other state. It is a Schedule III controlled substance, which means the DEA recognizes an accepted medical use, and clinicians prescribe it off-label for depression, anxiety, and PTSD. At-home sublingual ketamine through telehealth is available to eligible adults in Chicago now.

Psilocybin and MDMA, by contrast, remain illegal for therapy in Illinois. Psilocybin is a Schedule I substance under state law, and there is no licensed access program.¹⁰ A state bill, the CURE Act (HB1143), would create a regulated psilocybin program, but it has not passed and remains pending in committee, so it changes nothing about what is available today.¹¹ In 2019 the Chicago City Council took up a resolution urging that entheogenic plants be treated as a low law-enforcement priority, but that measure was non-binding and symbolic and did not decriminalize psilocybin.¹² For now, ketamine is the psychedelic-class therapy Chicagoans can legally access, and Mindbloom delivers it from home.

How At-Home Ketamine Therapy Works With Mindbloom

Care starts with an online medical intake and a video evaluation with an Illinois-licensed clinician, who reviews your history and decides whether ketamine is appropriate for you. If it is, you receive a personalized plan and a Bloombox toolkit, and a required peer treatment monitor is present for every session. You do the sessions at home, guided by the Mindbloom app, and follow them with structured integration, including one-to-one coaching and daily Integration Circles. Treatment frequency is personalized and clinician guided rather than a fixed schedule, and the benefits tend to build cumulatively alongside the more immediate relief many people feel early on.

Safety and Who Ketamine Therapy Is For

Ketamine therapy is a prescription medical treatment for eligible adults, not something available on demand. A licensed clinician confirms eligibility before treatment begins and screens for conditions where ketamine is not appropriate, such as uncontrolled hypertension, psychotic disorders, or substance use disorders. Common side effects include dissociation, increased blood pressure, nausea, and dizziness, and you should not drive until the day after a session. Ketamine is not FDA approved for depression, anxiety, or PTSD, and is prescribed off-label based on a clinician's judgment.

Cost and Insurance for Ketamine Therapy in Chicago

At-home ketamine therapy with Mindbloom runs about $165 to $215 per session within a program, and you can see current program pricing on the pricing page. Sessions are HSA and FSA eligible, and Mindbloom provides superbills you can submit for possible out-of-network reimbursement. In-clinic ketamine in Chicago generally runs higher per session, roughly $300 to $500 or more, and Spravato may be covered by insurance for those who qualify, subject to the insurer's approval.

Working Alongside Your Therapist

Ketamine therapy works best as part of your broader care, not a replacement for it. Mindbloom coordinates with your existing therapist or prescriber where that helps, and its programs are built around preparation and integration so the work continues between sessions. If you are starting without a therapist, the program structure provides that guided support directly.

Ketamine and Psychedelic Therapy Across Chicagoland

Because Mindbloom is delivered by telehealth, at-home ketamine therapy reaches eligible adults anywhere in the metro with an Illinois address. That includes the city itself, from the Loop and River North to North Side neighborhoods like Lincoln Park, Lakeview, and Hyde Park, along with suburbs such as Evanston, Oak Park, River Forest, Skokie, Cicero, Oak Lawn, Schaumburg, and out toward Naperville. Wherever you are in Chicagoland, care does not depend on driving to a clinic. Eligibility begins with an online clinician evaluation.